Maria de Miguel Solis
MD, PhD
Clinical Investigator, Drug Development Unit
👥Biography 个人简介
Dr. Maria de Miguel Solis is an early-phase clinical investigator at VHIO focused on antibody-drug conjugates. She has studied ADCs targeting B7-H3, Nectin-4, and other emerging targets in basket Phase I/II trials. Her work encompasses biomarker development, pharmacokinetics, and tumor target expression profiling to inform patient selection for novel ADC therapeutics.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Maria de Miguel Solis 的研究动态
Follow Maria de Miguel Solis's research updates
留下邮箱，当我们发布与 Maria de Miguel Solis（Vall d'Hebron Institute of Oncology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment